Format

Send to

Choose Destination
See comment in PubMed Commons below

3-(4-Hydroxy-3-[125I]iodophenyl)propionate-exendin(9-39).

Authors

Leung K1.

Source

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2010 Apr 06 [updated 2010 Jun 18].

Author information

1
National Center for Biotechnology Information, NLM, NIH, Bethesda, MD

Excerpt

Glucagon-like peptide-1 (GLP-1), composed of 30 amino acids (7–36), is secreted from enteroendocrine cells of the distal small intestine in response to food ingestion (1). GLP-1 plays an important role in glucose metabolism and homeostasis. It inhibits gastric emptying, glucagon secretion, and glucose production (2); it also induces insulin release from the pancreatic β-cells as well as their proliferation. The GLP-1 receptor has been identified in normal tissues, such as the pancreas, stomach, brain, and lung, and it has been shown to be highly overexpressed in human insulinomas and gastrinomas (3). In insulinomas, GLP-1 receptor density is considerably higher and is expressed more often than somatostatin receptors. Exendin, isolated from the venom of the lizard Heloderma suspectum (4), is a specific and competitive antagonist of GLP-1. Exendin(9-39) shares 53% sequence homology with GLP-1. Exendin(9-39) has been labeled with [125I]-Bolton-Hunter reagent (N-succinimidyl-3-(4-hydroxy-3-[125I]iodophenyl)propionate) at the Lys residues for single-photon emission computed tomography imaging of the GLP-1 receptor (5).

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons
    Support Center